Daniel Meyer is the Chief Executive Officer of CellChorus (cellchorus.com). Dan is an early stage entrepreneur and investor with experience across software, hardware and services companies in life sciences and information technology. He was the Chief Operating Officer and a board member of Genospace, an information platform for applied molecular and precision medicine, until its acquisition by HCA Healthcare (NYSE:HCA). Dan was a member of the venture capital investment teams at Arboretum Ventures and PJC.vc, where he covered investments in life science research products, medical devices, and digital health. He was a member of the healthcare investment banking group at Credit Suisse First Boston. He holds a B.A. in mathematics and economics from Middlebury College and an M.B.A. from the Tuck School of Business at Dartmouth.